Background: Experiences from infectious outbreaks globally, such as Ebola and severe acute respiratory syndrome (SARS), highlight the challenges of government to maintain essential healthcare services, guarantee healthcare access and at the same time shift resources to contain and mitigate the crisis. The declaration of the State of Disaster in South Africa due to the COVID 19 pandemic (on the 15th of March) and the subsequent imposition of a total national lockdown on all usual activities were anticipated to have both direct and indirect negative consequences on healthcare utilisation including reproductive healthcare services. Objective: The objective of this study is to describe the effect of the COVID-19 pandemic on family planning and termination of pregnancy services utilisation immediately following the lockdown in Gauteng Province. Methods: We analysed the administrative data on clinical services utilisation during the previous two years, including five weeks following the enforcement of the lockdown in South Africa, from the District Health Information System database over the period 1 April 2018-30 April 2020. Results: Primary healthcare utilisation headcounts across the province declined by nearly 500,000 visits following the lockdown period. Family planning utilisation patterns which are demand-driven declined during the two months preceding the COVID-19 pandemic and further declined during the lockdown. Switching contraceptive methods to those with less effectiveness were noted as a trend over the previous two years. Year on year comparisons from April 2018 to April 2020 indicated a consistent decline in the use of injectable methods and increased use of oral contraceptive pills. Conclusion: This review highlights the importance of monitoring the utilisation of routine healthcare services during the outbreak situations to ensure that service provision is not compromised. Women of reproductive age must be able to exercise their reproductive choices to prevent unintended pregnancies and to reduce their risk of mortality as a result of diminished access to reproductive healthcare services.

No abstract

BackgroundThere is scanty or inconclusive evidence on which cervical cancer screening tool is effective and suitable for human immunodeficiency virus (HIV)-seropositive women. The aim of this review was to assess, synthesise and document published evidence relating to the available cervical cancer screening modalities for HIV-seropositive women in developing countries. This paper did not review the issue of human papillomavirus (HPV) prophylactic vaccine on HIV-seropositive women.MethodsFive electronic databases were systematically searched from inception to January 2018 for relevant published original research examining cervical cancer prevention modalities for HPV infection, abnormal cytology and direct visualisation of the cervix amongst HIV-seropositive women in developing countries. Extra studies were identified through reference list and citation tracking.ResultsDue to methodological and clinical heterogeneity, a narrative synthesis was presented. Of the 2559 articles, 149 underwent full-text screening and 25 were included in the review. Included studies were of moderate quality, and no exclusions were made based on quality or bias. There is no standard cervical cancer screening test or programme for HIV-seropositive women and countries screening according to available resources and expertise. The screening methods used for HIV-seropositive women are the same for HIV-negative women, with varying clinical performance and accuracy. The main cervical cancer screening methods described for HIV-seropositive women are HPV deoxyribonucleic acid/messenger RNA (DNA/mRNA) testing (n = 16, 64.0%), visual inspection with acetic acid (VIA) (n = 13, 52.0%) and Pap smear (n = 11, 44.0%). HPV testing has a better accuracy/efficiency than other methods with a sensitivity of 80.0–97.0% and specificity of 51.0–78.0%. Sequential screening using VIA or visual inspection with Lugol’s iodine (VILI) and HPV testing has shown better clinical performance in screening HIV-seropositive women.ConclusionAlthough cervical cancer screening exists in almost all developing countries, what is missing is both opportunistic and systematic organised population-based screenings. Cervical cancer screening programmes need to be integrated into already existing HIV services to enable early detection and treatment. There is a need to offer opportunistic and coordinated screening programmes that are provider-initiated to promote early identification of cervical precancerous lesions.Systematic review registrationPROSPERO CRD42018095702Electronic supplementary materialThe online version of this article (10.1186/s13643-018-0874-7) contains supplementary material, which is available to authorized users.

Background The rise in cervical cancer trends in the past two decades has coincided with the human immunodeficiency virus (HIV) epidemic especially in the sub-Saharan African region. Young people (15 to 24 years old) are associated with many risk factors such as multiple sexual partners, early sexual debut, and high HIV incidences, which increase the chances of developing cervical cancer. The National Cancer Prevention and Control Strategy for Zimbabwe (2014–2018) highlights that no cancer communication strategy focusing on risk factors as primary cancer prevention. Therefore, the study aims to determine the knowledge, attitude and practices of young people in Zimbabwe on cervical cancer, screening, human papillomavirus (HPV) and vaccination. Methods A cross-sectional survey assessing young people’s knowledge, attitude and practices concerning cervical cancer was conducted in five provinces in Zimbabwe. A total of 751 young people were recruited through a three-stage cluster design from high schools and universities. Knowledge, attitudes and practices were assessed using questions based and adapted from the concepts of the Health Belief Model (HBM) and the Cervical Cancer Measuring tool kit-United Kingdom (UK). Results Most young people, 87.47% (656/750) claimed to know what the disease called cervical cancer is, with a mean score of 89.98% [95% CI 73.71.11–96.64] between high school and 86.72% [95% CI 83.48–89.40] among university students. There was no significant difference in mean scores between high school and university students ( p = 0.676). A risk factor knowledge proficiency score of ≥13 out of 26 was achieved in only 13% of the high school respondents and 14% of the university respondents with a broad range of misconceptions about cervical cancer risk factors in both females and males. There was not much difference on comprehensive knowledge of cervical cancer and its risk factors between female and male students, with the difference in knowledge scores among high school ( p = 0.900) and university ( p = 0.324) students not statistically significant. In contrast, 43% of respondents heard of cervical cancer screening and prevention, and 47% knew about HPV transmission and prevention. Parents’ educational level, province and smoking, were some of the factors associated with knowledge of and attitude towards cervical among high school and university students. Conclusion This study revealed that young people in Zimbabwe have an idea about cervical cancer and the seriousness thereof, but they lack adequate knowledge of risk factors. Cervical cancer education and awareness emphasising causes, risk factors and care-seeking behaviours should be commissioned and strengthen at the community, provincial and national level. Developing a standard cervical cancer primary prevention tool that can be integrated into schools can be a ste...